🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/08/2025 21,42 21,65 20,45 20,71 -2,91% 5,63% 2.030.500
22/08/2025 20,92 21,70 20,72 21,33 +2,80% 4,67% 2.646.200
21/08/2025 19,97 20,95 19,82 20,75 +2,72% 5,66% 2.569.800
20/08/2025 19,83 20,56 19,56 20,20 +1,71% 5,02% 2.116.000
19/08/2025 19,84 20,13 19,42 19,86 -0,25% 3,58% 2.065.500
18/08/2025 20,50 20,75 19,89 19,91 -2,93% 4,20% 2.756.500
15/08/2025 18,77 20,58 18,73 20,51 +9,21% 9,89% 5.202.000
14/08/2025 18,69 18,88 18,14 18,78 -6,05% 3,96% 5.000.500
13/08/2025 18,18 20,00 18,10 19,99 +12,30% 10,48% 2.874.500
12/08/2025 17,25 18,13 17,22 17,80 +3,43% 5,27% 1.885.700
11/08/2025 16,30 17,22 15,81 17,21 +4,81% 8,65% 2.689.100
08/08/2025 15,55 16,48 15,01 16,42 +2,24% 9,45% 2.806.300
07/08/2025 16,41 16,49 15,68 16,06 -1,53% 4,91% 1.638.200
06/08/2025 16,29 16,73 15,83 16,31 -0,97% 5,49% 1.935.000
05/08/2025 16,40 16,61 16,13 16,47 +0,03% 2,93% 1.293.700
04/08/2025 16,13 16,63 15,96 16,47 +3,36% 4,12% 1.094.500
01/08/2025 15,50 16,00 15,50 15,93 +0,82% 3,26% 1.519.200
31/07/2025 15,93 16,05 15,58 15,80 +0,60% 2,93% 1.195.800
30/07/2025 16,26 16,55 15,51 15,71 -1,35% 6,37% 1.548.200
29/07/2025 16,56 16,69 15,82 15,92 -1,73% 5,25% 1.597.700
28/07/2025 16,09 16,50 15,93 16,20 +2,92% 3,57% 1.804.200
25/07/2025 16,12 16,31 15,62 15,74 -3,20% 4,28% 1.765.600
24/07/2025 15,92 16,52 15,65 16,26 +2,14% 5,46% 2.449.300
23/07/2025 15,42 16,62 15,14 15,92 +6,42% 9,60% 3.419.300
22/07/2025 14,65 15,04 14,30 14,96 +1,70% 5,02% 2.729.100
21/07/2025 16,96 17,00 14,33 14,71 -12,23% 15,77% 6.746.100
18/07/2025 19,05 19,33 16,67 16,76 -11,09% 13,94% 3.012.600
17/07/2025 18,35 19,05 18,10 18,85 +3,01% 5,15% 1.301.900
16/07/2025 17,87 18,43 17,75 18,30 +3,80% 3,81% 1.248.400
15/07/2025 18,79 18,91 17,59 17,63 -5,27% 7,03% 1.458.800